Lv4
580 积分 2023-05-15 加入
Formulation Matters: The Overlooked Engine of Stability and Success in Antibody–Drug Conjugates
15小时前
待确认
Antibody-drug conjugate design and mechanisms of action for cancer treatment: state of the art and beyond
7天前
已完结
SHR-A1811, a novel HER2-targeting antibody-drug conjugate, in advanced solid tumors (HORIZON-X): a global phase 1 trial
7天前
已完结
Multivalent linkers: A growing trend in antibody–drug conjugate development
27天前
已完结
Tumor Targeting with Peptide-Drug Conjugates: Showcasing Key Progress and Hurdles
30天前
已完结
Coibamide Analogue as a Novel-Class Payload for Antibody-Drug Conjugate
1个月前
已完结
Discovery and mechanism of negative allosteric modulation of the α7 nicotinic acetylcholine receptor by nanobodies
2个月前
已完结
Synergistic treatment of prostate cancer and multiple myeloma using CD46-targeted radioimmunotherapy-antibody drug conjugates
2个月前
已完结
Clinical overview of trophoblast surface antigen 2 antibody-drug conjugates in non–small cell lung cancer
2个月前
已完结
Mechanisms of action and resistance to anti-HER2 antibody-drug conjugates in breast cancer
2个月前
已完结
皖公网安备34019202002308
